eli lilly glp-1 medications portfolio The FDA approved a new pill from on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Lilly is now pharma's top
Description
With a light tropical flavour, prebiotic fibre, and three probiotic strains including Lactobacillus acidophilus and Bifidobacterium longum, its a comprehensive daily nutrition boost in one scoop
FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are commercially available
Access to the WeightCare One app to track progress and chat with nutritionists and trainers
Keep reading to learn more
Stopping semaglutide after weight loss requires careful planning
The approval pertains to the GLP-1 drug dubbed Xianweiying also known as ecnoglutide which Pfizer has just acquired in a billion-dollar deal.
